Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$836M |
| 2 |
Microsoft
MSFT
|
+$748M |
| 3 |
Cigna
CI
|
+$560M |
| 4 |
3M
MMM
|
+$558M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$568M |
| 2 |
Zoom
ZM
|
+$557M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$516M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$479M |
| 5 |
Unity
U
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.71% |
| 2 | Healthcare | 11.34% |
| 3 | Financials | 9.38% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Communication Services | 5.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Rogers Communications
RCI
$18.7B
| $70M | 0.01% |
1,815,278
+975,009
| +116% | +$43.1M |
|
1102
Sprott Physical Gold
PHYS
$15.9B
| $69.6M | 0.01% |
5,441,044
+599,168
| +12% | +$8.06M |
|
|
FSD
1103
DELISTED
FIRST TRUST HIGH INCOME LONG/SHORT FUND
FSD
| $69.4M | 0.01% |
6,404,889
+89,963
| +1% | +$1.06M |
|
1104
BioMarin Pharmaceuticals
BMRN
$13.3B
| $69.4M | 0.01% |
818,515
-225,802
| -22% | -$20.1M |
|
1105
Wynn Resorts
WYNN
$10.6B
| $69.2M | 0.01% |
1,098,466
-244,052
| -18% | -$15.2M |
|
1106
VanEck Fallen Angel High Yield Bond ETF
ANGL
$3.1B
| $69M | 0.01% |
2,629,675
-294,241
| -10% | -$8.14M |
|
1107
Ares Management
ARES
$31B
| $69M | 0.01% |
1,112,989
-51,686
| -4% | -$3.61M |
|
|
MRTX
1108
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $68.9M | 0.01% |
987,155
+81,721
| +9% | +$6.05M |
|
1109
Pacer Global Cash Cows Dividend ETF
GCOW
$3.48B
| $68.8M | 0.01% |
2,573,754
-155,834
| -6% | -$4.68M |
|
1110
Barclays
BCS
$94.2B
| $68.8M | 0.01% |
10,749,231
+484,641
| +5% | +$3.73M |
|
1111
VanEck Junior Gold Miners ETF
GDXJ
$8.54B
| $68.6M | 0.01% |
2,329,408
+753,952
| +48% | +$23.4M |
|
1112
Ingredion
INGR
$6.53B
| $68.6M | 0.01% |
852,153
-57,361
| -6% | -$5.03M |
|
1113
CRH
CRH
$66.9B
| $68.6M | 0.01% |
2,128,419
+392,521
| +23% | +$14.3M |
|
1114
ORIX
IX
$43.3B
| $68.5M | 0.01% |
4,849,000
-342,000
| -7% | -$5.59M |
|
1115
DraftKings
DKNG
$12B
| $68.4M | 0.01% |
4,517,451
+499,287
| +12% | +$7.94M |
|
1116
Cytokinetics
CYTK
$10.8B
| $68.3M | 0.01% |
1,410,366
-89,739
| -6% | -$4.32M |
|
1117
Sonoco
SON
$5.72B
| $68.2M | 0.01% |
1,201,404
-297,266
| -20% | -$18.3M |
|
|
BTX
1118
BlackRock Technology and Private Equity Term Trust
BTX
$1B
| $68M | 0.01% |
9,350,726
-26,466
| -0.3% | -$221K |
|
1119
BJs Wholesale Club
BJ
$12.3B
| $67.8M | 0.01% |
931,765
+287,857
| +45% | +$20.6M |
|
1120
Invesco S&P Ultra Dividend Revenue ETF
RDIV
$1.39B
| $67.8M | 0.01% |
1,797,103
+189,697
| +12% | +$7.93M |
|
1121
Invesco
IVZ
$14B
| $67.5M | 0.01% |
4,929,089
+94,381
| +2% | +$1.59M |
|
1122
Pembina Pipeline
PBA
$27.8B
| $67.4M | 0.01% |
2,220,523
+388,543
| +21% | +$13.9M |
|
1123
MakeMyTrip
MMYT
$5.73B
| $67.2M | 0.01% |
2,188,280
-106,640
| -5% | -$3.29M |
|
|
BTRS
1124
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $67.1M | 0.01% |
7,242,413
+2,193,051
| +43% | +$14.2M |
|
|
DAY
1125
DELISTED
Dayforce
DAY
| $66.9M | 0.01% |
1,197,892
+88,955
| +8% | +$5.19M |
|
Similar funds
Morgan Stanley's Q3 2022 Portfolio in Review
As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
- Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
- Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
- Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
- Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
- Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.